Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/17/2024
Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...
10/17/2024
NMPA Holds National Drug Distribution Supervision Work Conference
10/16/2024
Eli Lilly Expands Innovation Centers to Beijing with New Research Faci...
10/16/2024
TenNor Announces CNY 300M+ Financing to Support Development and Comme...
10/16/2024
Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...
10/16/2024
Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab
10/16/2024
GSK's Submits Priority Review Application for BCMA ADC in China
10/16/2024
Akeso Launches Phase 1/2 Trial of AK129 and AK117
10/16/2024
Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...
10/16/2024
Hinova Pharma Receives IND Approval for PROTAC Candidate HP568 in Chin...
10/16/2024
Novartis to Negotiate NRDL Inclusion of siRNA Cholesterol-Reduction Dr...
10/16/2024
NHSA Issues the Notice on Regulating the Management of Externally-fill...
10/16/2024
China's New Policies On Foreign Investment In Healthcare And Biotechno...
10/16/2024
China Biopharma Tracker – Q3 2024 (PharmaDJ)
10/16/2024
Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...
10/16/2024
As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...
10/15/2024
AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
10/15/2024
Wuhan iRegene Completes Over CNY 100M Series B Financing
10/15/2024
Akeso Secures $250M to Propel Global Expansion of Its Innovative Drug...
10/15/2024
BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
10/15/2024
Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
10/15/2024
China Expands Health Silk Road to Dominate Africa's Pharmaceutical Mar...
10/15/2024
Dizal's Sunvozertinib Granted BTD in China for Treatment-Naive EGFR Ex...
10/15/2024
China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
10/15/2024
NMPA Issues the Application Procedures and Dossier Requirements for th...
10/15/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
10/15/2024
Review of Online Drug Sales Growth in China 2021-2023
10/11/2024
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
10/11/2024
NMPA Announces Package Insert Revision of Sodium Gluconate Injection P...
10/11/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Model-I...
Page:
45
/
774
Total number of articles:
23207
:
[First]
[<<]
[43]
[44]
[45]
[46]
[47]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit